Hypertension: FORTZAAR is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate.
Hypertensive Patients With Left Ventricular Hypertrophy: FORTZAAR is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to BLACK patients.
FORTZAAR should not be initiated in patients who are intravascularly volume-depleted (e.g., those treated with high-dose diuretics).
FORTZAAR is not recommended for patients with severe renal impairment (creatinine clearance ≤30 mL/min) or for patients with hepatic impairment.
No initial dosage adjustment of HYZAAR is necessary for elderly patients. FORTZAAR should not be used as initial therapy in elderly patients.